16-BROMO-17,17-ETHYLENEDIOXY-1,3,5-ESTRATRIEN-3-OL
UNII W5WHR56DQJ

Substance Identification & Data

This profile provides standardized clinical and technical data for 16-bromo-17,17-ethylenedioxy-1,3,5-estratrien-3-ol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W5WHR56DQJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 63626-68-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

W5WHR56DQJ

CAS Registry Number

63626-68-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

16-BROMO-17,17-ETHYLENEDIOXY-1,3,5-ESTRATRIEN-3-OL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C20H25BrO3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WYIBGUUFQXYIQI-BBCBXFPWSA-N

Line notation for describing the chemical structure and connectivity of atoms.

Substance Type

16-Bromo-17,17-ethylenedioxy-1,3,5-estratrien-3-ol

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C[C@]12CC[C@@]3(c4ccc(cc4CC[C@]3([C@@]1(CC(C25OCCO5)Br)[H])[H])O)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 16-bromo-17,17-ethylenedioxy-1,3,5-estratrien-3-ol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.